Ovariamin®- Bioregulator of ovaries.
Recommended to improve function of the ovaries, infertility, as well as to reduce the negative manifestations of menopause.
In postmenopausal period in the reproductive system of women begin to dominate the involutional processes, and more intensely than in menopausal period, as the flow on the background of a sharp decline in the production of estradiol. In all the organs of the reproductive system occur atrophic changes: decreased uterine weight, its muscular elements are replaced by connective tissue thins the vaginal epithelium, the ovaries gradually shrink due to the development of connective tissue. Also, very importantly, at the same time atrophic changes occur in the tissues of the bladder, urethra, pelvic floor muscles. These processes are responsible for violations occurring functions of the urinary system, urinary incontinence and prolapse of the vaginal walls. Decreased estrogen content does not cause a response in the endometrium, and the lining of the uterus atrophies. On the background of the fall of the functional activity ovaries begin to develop metabolic (increased cholesterol in the blood), vegetative-vascular and psycho-emotional disorders, as well as cardiovascular disease and osteoporosis. For the correction of pathological changes, while developing functional and organic diseases of the ovaries, designed "Ovariamin."
Clinical trials of influence of "Ovariamin" conducted in 180 women with climacteric syndrome of various etiologies (involutional, postoperative), and depletion ovaries syndrome.
Effectiveness of "Ovariamin" evaluated the dynamics of complaints, according to laboratory, functional and instrumental studies.
Following a series of clinical trials, it was found that the use of "Ovariamin" in patients with various manifestations of the climacteric syndrome contributed to a significant improvement in their general condition, which manifested itself in improving sleep, mood and appetite, increase efficiency. On the background of course taking of "Ovariamin" occurred as a reduction of "hot flashes" and decrease of their intensity.
In a laboratory study of the neuroendocrine system of indicators showed a significant reduction in the levels of follicle stimulating hormone (FSH) in the blood, as well as a tendency to decrease adrenocorticotropic (ACTH) and thyroid-stimulating (TSH) hormones. Revealed changes in hormonal status of patients while receiving "Ovariamin" correlate with the positive dynamics of the clinical picture, which may indicate an increase in functional activity of the glandular tissue of the ovaries.
In female patients with wasting syndrome ovaries use "Ovariamin" in 58% of cases are caused by a normalization of the menstrual cycle, and helped reduce asthenovegetative asthenoneurotic manifestations of the disease.
These lab tests show an increase in size of the ovaries and increase their steroidogenic function, reduced anterior pituitary gonadotrophic function.
Analysis of the results of clinical studies leads to the conclusion that the course application of "Ovariamin" has a normalizing effect on the cellular metabolism ovaries, promotes the normalization process of the formation and maturation of follicles and recovery neurohumoral mechanisms of regulation of menstrual and reproductive functions.
"Ovariamin" is recommended for accelerated recovery of ovarian function in various forms of violations, including the negative manifestations of menopause in women. He also recommended that elderly women to maintain the function of the ovaries.
Indication of use:
1-3 tablets 2-3 times a day for 10-15 minutes before meals with water without chewing. Course: 10-14 days. Repeat the course in 3-6 months.
Individual intolerance to the product components, pregnancy, lactation.
40 tablets per pack